Ernexa Therapeutics Inc. (ERNA): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$3.75M
As of 2018-12-31
-20.4%
3-year compound annual growth
+18.7%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2018-12-31 | $3.75M | -26.8% | 2019-03-22, Balance as of period end |
| 2017-12-31 | $5.12M | -36.8% | 2018-03-09, Balance as of period end |
| 2016-12-31 | $8.11M | +9.0% | 2017-03-09, Balance as of period end |
| 2015-12-31 | $7.44M | +39.8% | 2016-03-15, Balance as of period end |
| 2014-12-31 | $5.32M | +233.9% | 2015-03-27, Balance as of period end |
| 2013-12-31 | $1.59M | n/a | 2014-03-31, Balance as of period end |